A Randomised Trial of Subcutaneous Intermittent Interleukin-2 without Antiretroviral Therapy in HIV-Infected Patients: The UK–Vanguard Study

OBJECTIVE: The objective of the trial was to evaluate in a pilot setting the safety and efficacy of interleukin-2 (IL-2) therapy when used without concomitant antiretroviral therapy as a treatment for HIV infection. DESIGN AND SETTING: This was a multicentre randomised three-arm trial conducted betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Youle, Mike, Emery, Sean, Fisher, Martin, Nelson, Mark, Fosdick, Lisa, Janossy, George, Loveday, Clive, Sullivan, Ann, Herzmann, Christian, Wand, Handan, Davey, Richard T, Johnson, Margaret A, Tavel, Jorge A, Lane, H. Clifford
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488892/
https://www.ncbi.nlm.nih.gov/pubmed/16871325
http://dx.doi.org/10.1371/journal.pctr.0010003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488892/
https://www.ncbi.nlm.nih.gov/pubmed/16871325
http://dx.doi.org/10.1371/journal.pctr.0010003

Ejemplares similares